制定控股公司
US ˙ NasdaqGS ˙ US29249E1091

簡介

本頁面提供了有關 Christopher J Coughlin 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Christopher J Coughlin已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:CNC / Centene Corporation Director 18,149
US:KRTX / Karuna Therapeutics, Inc. Director 0
US:PBH / Prestige Consumer Healthcare Inc. Director 13,218
US:US00C4W3Z001 / Alexion Pharmaceuticals, Inc. Director 0
US:ACT / Enact Holdings, Inc. Director 0
US:US26483EAL48 / Dun & Bradstreet Corp/The Director 38,317
US:HOLX / Hologic, Inc. Director 6,816
US:COV / Director 0
Director 0
US:DPRX / Dipexium Pharmaceuticals, Inc. Director 109,309
US:TYC / Tyco International plc EVP and CFO 184,700
如何解讀這些圖表

以下圖表顯示了在Christopher J Coughlin進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

ACT / Enact Holdings, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 ACT / Enact Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2018-09-06 AGN COUGHLIN CHRISTOPHER J 1,300 190.5500 1,300 190.5500 247,715 27
2018-09-06 AGN COUGHLIN CHRISTOPHER J 705 190.5600 705 190.5600 134,345
2018-09-06 AGN COUGHLIN CHRISTOPHER J 27 190.5700 27 190.5700 5,145
2018-09-06 AGN COUGHLIN CHRISTOPHER J 100 190.5800 100 190.5800 19,058
2018-09-06 AGN COUGHLIN CHRISTOPHER J 356 190.5900 356 190.5900 67,850
2018-09-06 AGN COUGHLIN CHRISTOPHER J 400 190.6000 400 190.6000 76,240
2018-09-06 AGN COUGHLIN CHRISTOPHER J 200 190.6100 200 190.6100 38,122
2018-09-06 AGN COUGHLIN CHRISTOPHER J 68 190.6200 68 190.6200 12,962
2018-09-06 AGN COUGHLIN CHRISTOPHER J 100 190.6500 100 190.6500 19,065
2018-09-06 AGN COUGHLIN CHRISTOPHER J 816 190.6600 816 190.6600 155,579
2018-09-06 AGN COUGHLIN CHRISTOPHER J 222 190.6700 222 190.6700 42,329
2018-09-06 AGN COUGHLIN CHRISTOPHER J 4,889 190.6800 4,889 190.6800 932,235
2018-09-06 AGN COUGHLIN CHRISTOPHER J 517 190.6400 517 190.6400 98,561
2018-09-06 AGN COUGHLIN CHRISTOPHER J 300 190.6300 300 190.6300 57,189
2017-12-05 AGN COUGHLIN CHRISTOPHER J 10,000 163.3000 10,000 163.3000 1,633,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACT / Enact Holdings, Inc. Insider Trades
ACT / Enact Holdings, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 ACT / Enact Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACT / Enact Holdings, Inc. Insider Trades
PBH / Prestige Consumer Healthcare Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 ACT / Enact Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

PBH / Prestige Consumer Healthcare Inc. Insider Trades
PBH / Prestige Consumer Healthcare Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 ACT / Enact Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

PBH / Prestige Consumer Healthcare Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Christopher J Coughlin 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-13 2026-05-12 4 CNC CENTENE CORP
Common Stock
A - Award 3,992 18,149 28.20
2026-03-31 2026-03-31 4 CNC CENTENE CORP
Common Stock
A - Award 1,140 14,157 8.76
2026-01-05 2025-12-31 4 CNC CENTENE CORP
Common Stock
A - Award 729 13,017 5.93
2025-10-01 2025-09-30 4 CNC CENTENE CORP
Common Stock
A - Award 852 12,288 7.45
2025-07-02 2025-06-30 4 CNC CENTENE CORP
Common Stock
A - Award 556 11,436 5.11
2025-05-14 2025-05-13 4 CNC CENTENE CORP
Common Stock
A - Award 3,579 10,880 49.02
2025-04-02 2025-03-31 4 CNC CENTENE CORP
Common Stock
A - Award 500 7,301 7.35
2025-01-03 2024-12-31 4 CNC CENTENE CORP
Common Stock
A - Award 497 6,801 7.88
2024-12-17 2024-12-16 4 CNC CENTENE CORP
Common Stock
P - Purchase 10,000 36,358 37.94 59.44 594,400 2,161,115
2024-10-02 2024-09-30 4 CNC CENTENE CORP
Common Stock
A - Award 402 26,358 1.55
2024-07-02 2024-06-30 4 CNC CENTENE CORP
Common Stock
A - Award 452 25,956 1.77
2024-05-24 3/A CNC CENTENE CORP
Common Stock
878
2024-05-24 2024-05-14 4 CNC CENTENE CORP
Common Stock
S - Sale -878 0 -100.00 76.74 -67,382
2024-05-16 2024-05-14 4 CNC CENTENE CORP
Common Stock
A - Award 2,916 25,504 12.91
2024-04-02 2024-03-31 4 CNC CENTENE CORP
Common Stock
A - Award 389 22,588 1.75
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -990 0 -100.00 330.00 -326,700
2024-01-03 2023-12-31 4 CNC CENTENE CORP
Common Stock
A - Award 502 22,199 2.32
2023-10-03 2023-09-30 4 CNC CENTENE CORP
Common Stock
A - Award 545 21,697 2.58
2023-07-05 2023-06-30 4 CNC CENTENE CORP
Common Stock
A - Award 544 21,152 2.64
2023-06-22 2023-06-20 4 KRTX Karuna Therapeutics, Inc.
Common Stock
A - Award 990 990
2023-05-12 2023-05-10 4 CNC CENTENE CORP
Common Stock
A - Award 2,947 20,608 16.69
2023-04-04 2023-03-31 4 CNC CENTENE CORP
Common Stock
A - Award 511 17,661 2.98
2023-01-04 2022-12-31 4 CNC CENTENE CORP
Common Stock
A - Award 444 17,151 2.66
2022-10-04 2022-09-30 4 CNC CENTENE CORP
Common Stock
A - Award 406 16,707 2.49
2022-08-03 2022-08-02 4 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
A - Award 2,495 13,218 23.27
2022-07-05 2022-06-30 4 CNC CENTENE CORP
Common Stock
A - Award 436 16,301 2.75
2022-05-03 2022-04-29 4 CNC CENTENE CORP
Common Stock
P - Purchase 12,000 15,865 310.48 81.37 976,440 1,290,932
2022-04-28 2022-04-26 4 CNC CENTENE CORP
Common Stock
A - Award 2,323 3,865 150.65
2022-04-04 2022-03-31 4 CNC CENTENE CORP
Common Stock
A - Award 442 1,542 40.18 82.02 36,250 126,472
2022-02-09 2022-02-07 4 CNC CENTENE CORP
Common Stock Option (right to buy)
A - Award 10,000 10,000
2022-02-09 2022-02-07 4 CNC CENTENE CORP
Common Stock
A - Award 1,100 1,100
2022-01-14 3 CNC CENTENE CORP
No Securities Beneficially Owned
0
2021-08-05 2021-08-03 4 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
A - Award 2,808 10,723 35.48
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
D - Sale to Issuer -2,343 0 -100.00 155.01 -363,188
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
D - Sale to Issuer -2,706 0 -100.00 167.97 -454,527
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
D - Sale to Issuer -2,294 0 -100.00 138.86 -318,545
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
D - Sale to Issuer -42,347 0 -100.00
2021-06-23 2021-06-16 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 8,500 8,500
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 729 42,347 1.75
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 1,962 41,618 4.95
2020-08-06 2020-08-04 4 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
A - Award 3,732 7,915 89.22
2020-05-18 2020-05-14 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 2,774 39,656 7.52
2020-05-18 2020-05-14 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 3,468 36,882 10.38
2020-05-11 2020-05-08 4 AGN Allergan plc
Stock Options
D - Sale to Issuer -9,446 0 -100.00
2020-05-11 2020-05-08 4 AGN Allergan plc
Stock Options
D - Sale to Issuer -3,691 0 -100.00
2020-05-11 2020-05-08 4 AGN Allergan plc
Stock Options
D - Sale to Issuer -2,790 0 -100.00
2020-05-11 2020-05-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
D - Sale to Issuer -16,532 0 -100.00
2020-05-11 2020-05-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
D - Sale to Issuer -9,538 16,542 -36.57
2020-05-11 2020-05-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
D - Sale to Issuer -471 26,080 -1.77
2020-05-04 2020-05-01 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -991 16,542 -5.65 189.74 -188,032 3,138,679
2020-04-28 2020-04-24 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 25,000 25,000
2020-02-13 2019-06-18 5 AGN Allergan plc
Ordinary Shares, par value $0.0001
G - Gift -9,538 12,776 -42.74
2019-08-01 3 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
0
2019-08-01 2019-07-30 4 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
A - Award 4,183 4,183
2019-05-17 2019-05-15 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 2,181 33,414 6.98
2019-05-17 2019-05-15 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 2,726 31,233 9.56
2019-05-02 2019-05-02 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 2,064 17,080 13.75 145.33 299,961 2,482,236
2019-05-02 2019-04-30 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -953 15,016 -5.97 147.00 -140,091 2,207,352
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 300 16,431 1.86 190.63 57,189 3,132,242
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 517 16,131 3.31 190.64 98,561 3,075,214
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 4,889 15,614 45.59 190.68 932,235 2,977,278
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 222 10,725 2.11 190.67 42,329 2,044,936
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 816 10,503 8.42 190.66 155,579 2,002,502
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 100 9,687 1.04 190.65 19,065 1,846,827
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 68 9,587 0.71 190.62 12,962 1,827,474
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 200 9,519 2.15 190.61 38,122 1,814,417
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 400 9,319 4.48 190.60 76,240 1,776,201
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 356 8,919 4.16 190.59 67,850 1,699,872
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 100 8,563 1.18 190.58 19,058 1,631,937
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 27 8,463 0.32 190.57 5,145 1,612,794
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 705 8,436 9.12 190.56 134,345 1,607,564
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 1,300 7,731 20.21 190.55 247,715 1,473,142
2018-05-11 2018-05-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 2,174 28,507 8.26
2018-05-04 2018-05-02 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 1,985 6,431 44.65 151.07 299,874 971,531
2018-05-04 2018-02-28 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
G - Gift -10,000 4,446 -69.22
2018-05-02 2018-04-30 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
P - Purchase 10,000 26,333 61.23 120.79 1,207,900 3,180,763
2017-12-05 2017-12-05 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 10,000 14,446 224.92 163.30 1,633,000 2,359,032
2017-12-05 2017-12-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 10,000 16,333 157.90 112.75 1,127,500 1,841,546
2017-06-16 2017-06-15 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
P - Purchase 2,000 6,333 46.16 117.10 234,200 741,594
2017-05-12 2017-05-10 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 2,030 4,333 88.15
2017-05-05 2017-05-04 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 1,223 4,446 37.95 245.25 299,941 1,090,382
2017-05-05 2017-05-03 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -668 3,223 -17.17 243.76 -162,832 785,638
2017-03-13 2017-03-10 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 175 38,317 0.46 40.29 7,054 1,543,796
2017-03-13 2017-03-10 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 75 16,536 0.45 107.81 8,048 1,782,736
2017-03-09 2017-03-08 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 6,816 6,816
2017-03-09 2017-03-08 4 HOLX HOLOGIC INC
Restricted Stock Unit Award (Right To Receive)
M - Exercise -2,427 0 -100.00
2017-03-09 2017-03-08 4 HOLX HOLOGIC INC
Common Stock
A - Award 2,206 7,633 40.65
2017-03-09 2017-03-08 4 HOLX HOLOGIC INC
Common Stock
M - Exercise 2,427 5,427 80.90
2017-02-02 2017-01-31 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 728 38,142 1.95 45.73 33,301 1,744,235
2017-01-27 2017-01-26 4 DNB DUN & BRADSTREET CORP/NW
Non-Qualified Stock Option (right to buy)
M - Exercise -2,086 0 -100.00
2017-01-27 2017-01-26 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
M - Exercise 2,086 18,547 12.67 88.04 183,651 1,632,901
2016-12-13 2016-12-09 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 144 37,414 0.39 46.00 6,605 1,721,035
2016-12-13 2016-12-09 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 63 16,461 0.38 122.96 7,698 2,024,035
2016-09-13 2016-09-09 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 133 37,270 0.36 49.52 6,580 1,845,622
2016-09-13 2016-09-09 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 57 16,399 0.35 134.56 7,670 2,206,603
2016-08-17 2016-08-15 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -100 3,891 -2.51 254.05 -25,405 988,509
2016-08-09 2016-08-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 201 3,991 5.30 248.31 49,910 991,005
2016-07-05 2016-06-30 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2,300 37,137 6.60 45.44 104,500 1,687,521
2016-06-14 2016-06-10 4 DNB DUN & BRADSTREET CORP/NW
Phanton Stock Units - Deferred Compensation
A - Award 131 34,838 0.38 46.88 6,159 1,633,188
2016-06-14 2016-06-10 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 61 16,342 0.37 126.04 7,641 2,059,620
2016-05-13 2016-05-11 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 2,294 2,294 138.86 318,545 318,545
2016-05-13 2016-05-11 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 835 2,303 56.88
2016-05-09 2016-05-05 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 1,188 3,790 45.66 210.34 249,884 797,189
2016-05-06 2016-05-04 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 1,087 16,281 7.15
2016-03-15 2016-03-11 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 164 34,706 0.48 37.41 6,147 1,298,360
2016-03-15 2016-03-11 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 72 15,194 0.47 98.98 7,082 1,503,828
2016-03-04 2016-03-02 4 HOLX HOLOGIC INC
Restricted Stock Unit Award (Right To Receive)
A - Award 2,427 2,427
2016-03-04 2016-03-02 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 7,402 7,402
2016-03-04 3 HOLX HOLOGIC INC
Common Stock
6,000
2016-03-04 3 HOLX HOLOGIC INC
Common Stock
6,000
2016-02-02 2016-01-29 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2,837 34,542 8.95 36.84 104,500 1,272,524
2015-12-15 2015-12-11 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 140 31,705 0.44 38.55 5,382 1,222,240
2015-12-15 2015-12-11 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 65 15,122 0.43 103.68 6,758 1,567,898
2015-11-10 2015-11-06 4 DNB DUN & BRADSTREET CORP/NW
Non-Qualified Stock Option - right to buy
M - Exercise -2,330 0 -100.00
2015-11-10 2015-11-06 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
S - Sale -2,330 15,057 -13.40 112.50 -262,134 1,694,003
2015-11-10 2015-11-06 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
M - Exercise 2,330 17,387 15.47 71.28 166,071 1,239,279
2015-09-15 2015-09-11 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 136 31,566 0.43 39.26 5,351 1,239,270
2015-09-15 2015-09-11 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 64 15,057 0.43 104.56 6,729 1,574,390
2015-08-25 2015-08-23 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -124 2,602 -4.55 298.57 -37,023 776,879
2015-08-18 2015-08-15 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -100 2,726 -3.54 314.50 -31,450 857,327
2015-07-01 2015-06-30 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2,296 31,429 7.88 45.52 104,500 1,430,668
2015-06-30 2015-06-05 4/A AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 826 2,826 41.30 302.30 249,700 854,300
2015-06-30 2015-06-04 4/A AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -334 2,000 -14.31 303.38 -101,329 606,760
2015-06-16 2015-06-12 4 DNB DUN & BRADSTREET CORP/NW
Phanton Stock Units - Deferred
A - Award 102 29,134 0.35 48.14 4,931 1,402,498
2015-06-16 2015-06-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 52 14,993 0.35 129.73 6,705 1,945,033
2015-06-08 2015-06-05 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 826 2,826 41.30 302.30 249,700 854,300
2015-06-08 2015-06-04 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
F - Taxes -334 2,000 -14.31 303.38 -101,329 606,760
2015-05-08 2015-05-06 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 2,343 2,343 155.01 363,188 363,188
2015-05-08 2015-05-06 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 700 1,468 91.15
2015-05-08 2015-05-06 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 954 14,941 6.82
2015-03-13 2015-03-11 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred
A - Award 104 29,031 0.36 47.20 4,911 1,370,277
2015-03-13 2015-03-11 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 49 13,987 0.35 127.20 6,241 1,779,249
2015-02-03 2015-01-30 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2,431 28,927 9.17 42.99 104,500 1,243,583
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -55,004 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -55,004 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -10,521 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -14,109 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -7,970 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -49,475 0 -100.00
2014-12-16 2014-12-12 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 100 26,496 0.38 42.50 4,271 1,126,100
2014-12-16 2014-12-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 51 13,938 0.37 114.86 5,914 1,600,871
2014-11-03 2014-10-30 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 694 18,261 3.95 243.21 168,788 4,441,258
2014-09-16 2014-09-12 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 98 26,396 0.37 43.67 4,259 1,152,712
2014-09-16 2014-09-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 50 13,887 0.36 117.04 5,892 1,625,369
2014-07-24 2014-07-22 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 2,706 2,706 167.97 454,527 454,527
2014-07-24 2014-07-22 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 768 768
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Stock Option (Right to Buy)
D - Sale to Issuer -5,909 0 -100.00
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Stock Option (Right to Buy)
D - Sale to Issuer -7,815 0 -100.00
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Stock Option (Right to Buy)
D - Sale to Issuer -20,000 0 -100.00
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Restricted Stock
D - Sale to Issuer -2,406 0 -100.00
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Common Stock
D - Sale to Issuer -1,527 0 -100.00
2014-07-03 2014-07-01 4 ACT Actavis plc
Stock Option (Right to Buy)
A - Award 2,790 2,790
2014-07-03 2014-07-01 4 ACT Actavis plc
Stock Option (Right to Buy)
A - Award 3,691 3,691
2014-07-03 2014-07-01 4 ACT Actavis plc
Stock Option (Right to Buy)
A - Award 9,446 9,446
2014-07-03 2014-07-01 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 1,640 1,640
2014-07-02 2014-07-01 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2,501 26,298 10.51 41.79 104,500 1,099,012
2014-06-17 2014-06-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 99 23,798 0.42 38.88 3,844 925,260
2014-06-17 2014-06-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 57 13,836 0.41 103.94 5,891 1,438,151
2014-05-23 2014-05-21 4 COV Covidien plc
Ordinary Shares
A - Award 420 49,446 0.86
2014-05-09 2014-05-07 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 1,141 13,780 9.03
2014-03-21 2014-03-19 4 COV Covidien plc
Ordinary Shares
F - Taxes -1,046 49,016 -2.09 70.68 -73,931 3,464,451
2014-03-21 2014-03-19 4 COV Covidien plc
Ordinary Shares
A - Award 2,264 50,062 4.74
2014-03-20 2014-03-18 4 DPRX Dipexium Pharmaceuticals, Inc.
Common Stock, par value $.001 per share
P - Purchase 2,083 109,309 1.94 12.00 24,996 1,311,708
2014-03-14 2014-03-12 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 104 23,699 0.44 36.77 3,823 871,411
2014-03-14 2014-03-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 54 12,639 0.43 98.08 5,341 1,239,601
2014-03-12 3 DPRX Dipexium Pharmaceuticals, LLC
Common Stock, par value $.001 per share
214,452
2014-03-12 3 DPRX Dipexium Pharmaceuticals, LLC
Common Stock, par value $.001 per share
214,452
2014-02-24 2014-02-20 4 COV Covidien plc
Ordinary Shares
A - Award 12 47,798 0.03 71.28 855 3,407,041
2014-02-04 2014-01-31 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2,544 23,595 12.08 41.08 104,500 969,282
2013-12-17 2013-12-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 72 21,051 0.34 42.99 3,087 904,990
2013-12-17 2013-12-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 42 12,584 0.33 116.06 4,839 1,460,524
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Non-Qualified Stock Option - right to buy
M - Exercise -2,746 0 -100.00
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Non-Qualified Stock Option - right to buy
M - Exercise -1,573 0 -100.00
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
S - Sale -4,319 12,543 -25.61 110.75 -478,335 1,389,100
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
M - Exercise 2,746 16,862 19.45 60.54 166,229 1,020,712
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
M - Exercise 1,573 14,116 12.54 59.86 94,160 844,955
2013-11-07 2013-11-05 4 COV Covidien plc
Ordinary Shares
A - Award 13 47,786 0.03 64.33 836 3,074,073
2013-10-24 2013-10-22 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1,374 20,979 7.01 40.02 55,000 839,595
2013-09-20 2013-09-18 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 72 19,605 0.37 40.32 2,884 790,476
2013-09-20 2013-09-18 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 45 12,543 0.36 106.96 4,821 1,341,548
2013-08-16 2013-08-15 4 FRX FOREST LABORATORIES INC
Stock Option (Right to Buy)
A - Award 5,909 5,909
2013-08-16 2013-08-15 4 FRX FOREST LABORATORIES INC
Common Stock
A - Award 1,761 3,933 81.08
2013-08-16 2013-08-15 4 COV Covidien plc
Ordinary Shares
A - Award 11 47,773 0.02 61.85 680 2,954,760
2013-07-19 2013-07-17 4 COV Covidien plc
Ordinary Shares
A - Award 248 47,762 0.52
2013-07-03 2013-07-01 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1,647 19,534 9.21 36.74 60,500 717,662
2013-06-17 2013-06-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 70 17,887 0.40 37.25 2,626 666,285
2013-06-17 2013-06-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 49 12,497 0.39 98.79 4,802 1,234,623
2013-05-07 2013-05-03 4 COV Covidien plc
Ordinary Shares
A - Award 8 47,302 0.02 64.35 515 3,043,884
2013-03-22 2013-03-20 4 COV Covidien plc
Ordinary Shares
F - Taxes -1,052 47,294 -2.18 65.50 -68,906 3,097,757
2013-03-22 2013-03-20 4 COV Covidien plc
Ordinary Shares
A - Award 2,214 48,346 4.80
2013-03-18 2013-03-14 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 86 17,816 0.48 30.51 2,622 543,577
2013-03-18 2013-03-14 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 59 12,449 0.47 81.23 4,778 1,011,219
2013-02-21 2013-02-19 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 1,453 12,390 13.29 82.56 119,952 1,022,858
2013-02-06 2013-02-05 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -12,000 0 -100.00
2013-02-06 2013-02-05 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -12,000 0 -100.00
2013-02-06 2013-02-05 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -12,000 0 -100.00
2013-02-06 2013-02-05 4 COV Covidien plc
Ordinary Shares
S - Sale -36,000 0 -100.00 62.05 -2,233,800
2013-02-06 2013-02-05 4 COV Covidien plc
Ordinary Shares
M - Exercise 12,000 36,000 50.00 36.99 443,884 1,331,651
2013-02-06 2013-02-05 4 COV Covidien plc
Ordinary Shares
M - Exercise 12,000 24,000 100.00 45.45 545,364 1,090,728
2013-02-06 2013-02-05 4 COV Covidien plc
Ordinary Shares
M - Exercise 12,000 12,000 45.66 547,890 547,890
2013-02-05 2013-02-01 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1,950 17,730 12.36 31.03 60,500 550,175
2012-12-28 2012-12-27 4 COV Covidien plc
Ordinary Shares
A - Award 12 46,132 0.03 57.35 688 2,645,670
2012-12-17 2012-12-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 73 15,781 0.46 30.26 2,209 477,524
2012-12-17 2012-12-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 49 10,937 0.45 80.90 3,968 884,750
2012-11-07 2012-11-05 4 COV Covidien plc
Ordinary Shares
A - Award 13 46,120 0.03 55.65 723 2,566,578
2012-09-20 2012-09-18 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 71 15,708 0.45 31.27 2,205 491,180
2012-09-20 2012-09-18 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 47 10,888 0.44 83.39 3,950 907,947
2012-08-27 2012-08-23 4 FRX FOREST LABORATORIES INC
Stock Option (Right to Buy)
A - Award 7,815 7,815
2012-08-27 2012-08-23 4 FRX FOREST LABORATORIES INC
Common Stock
A - Award 2,172 2,172
2012-08-20 2012-08-16 4 COV Covidien plc
Ordinary Shares
A - Award 10 46,107 0.02 57.59 576 2,655,302
2012-07-05 2012-07-02 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1,836 15,229 13.71 26.96 49,500 410,578
2012-06-15 2012-06-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 73 13,393 0.55 25.56 1,879 342,328
2012-06-15 2012-06-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 58 10,841 0.54 67.32 3,928 729,734
2012-05-11 2012-05-09 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 134 13,320 1.02 23.85 3,203 317,673
2012-05-09 2012-05-07 4 COV Covidien plc
Ordinary Shares
A - Award 11 46,097 0.02 54.25 597 2,500,762
2012-03-16 2012-03-14 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 50 13,185 0.38 32.18 1,608 424,303
2012-03-16 2012-03-14 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 46 10,782 0.42 85.90 3,911 926,248
2012-03-14 2012-03-13 4 COV Covidien plc
Ordinary Shares
F - Taxes -1,033 46,086 -2.19 53.89 -55,668 2,483,575
2012-03-14 2012-03-13 4 COV Covidien plc
Ordinary Shares
A - Award 2,691 47,119 6.06
2012-03-05 2012-03-01 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1,590 13,135 13.77 31.14 49,500 409,034
2012-02-24 2012-02-22 4 COV Covidien plc
Ordinary Shares
A - Award 11 44,428 0.02 52.45 577 2,330,249
2012-02-15 2012-02-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 1,517 10,737 16.45 79.10 120,002 849,327
2008-10-09 2008-10-07 4 TYC TYCO INTERNATIONAL LTD /BER/
Stock Option (Right to Buy)
A - Award 184,700 184,700
2008-10-09 2008-10-07 4 TYC TYCO INTERNATIONAL LTD /BER/
Performance Share Units
A - Award 51,700 94,900 119.68
2005-08-08 2005-08-05 4 TYC TYCO INTERNATIONAL LTD /BER/
Common Shares
P - Purchase 10,000 110,000 10.00 27.24 272,400 2,996,400
2005-03-07 3 TYC TYCO INTERNATIONAL LTD /BER/
Common Shares
0
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)